Proteoglycans in cancer | 5.75E-08 | 145 | 76 |
Hippo signaling pathway | 1.04E-07 | 113 | 74 |
Arrhythmogenic right ventricular cardiomyopathy (ARVC) | 6.54E-07 | 57 | 72 |
Adherens junction | 6.54E-07 | 62 | 75 |
Renal cell carcinoma | 2.40E-06 | 56 | 74 |
Wnt signaling pathway | 2.99E-06 | 107 | 76 |
Fatty acid biosynthesis | 1.25E-05 | 9 | 50 |
ECM-receptor interaction | 1.25E-05 | 56 | 70 |
Axon guidance | 1.58E-05 | 94 | 75 |
FoxO signaling pathway | 4.68E-05 | 100 | 76 |
Ubiquitin mediated proteolysis | 5.75E-05 | 102 | 76 |
Pathways in cancer | 6.76E-05 | 275 | 76 |
ErbB signaling pathway | 8.02E-05 | 66 | 75 |
Pancreatic cancer | 0.000165 | 53 | 73 |
TGF-beta signaling pathway | 0.000234 | 57 | 73 |
Focal adhesion | 0.000234 | 147 | 74 |
Rap1 signaling pathway | 0.000234 | 148 | 76 |
Gap junction | 0.000753 | 64 | 76 |
Long-term depression | 0.000962 | 45 | 73 |
N-Glycan biosynthesis | 0.001119 | 33 | 69 |
Prion diseases | 0.001166 | 20 | 66 |
Endocytosis | 0.001469 | 140 | 75 |
Fatty acid metabolism | 0.001547 | 31 | 69 |
Endometrial cancer | 0.001567 | 41 | 72 |
Signaling pathways regulating pluripotency of stem cells | 0.001567 | 99 | 76 |
Prostate cancer | 0.001769 | 66 | 75 |
Colorectal cancer | 0.002458 | 49 | 72 |
Cell cycle | 0.002703 | 89 | 73 |
PI3K-Akt signaling pathway | 0.002703 | 225 | 76 |
Melanoma | 0.00405 | 54 | 73 |
Circadian rhythm | 0.00591 | 26 | 70 |
Prolactin signaling pathway | 0.006364 | 50 | 75 |
Adrenergic signaling in cardiomyocytes | 0.006716 | 97 | 77 |
Glycosaminoglycan biosynthesis - heparan sulfate / heparin | 0.006964 | 17 | 62 |
Dorso-ventral axis formation | 0.011682 | 23 | 73 |
AMPK signaling pathway | 0.012171 | 87 | 75 |
Glioma | 0.012308 | 45 | 72 |
Tight junction | 0.012616 | 98 | 76 |
Thyroid hormone signaling pathway | 0.01495 | 79 | 72 |
Morphine addiction | 0.01495 | 63 | 73 |
Oocyte meiosis | 0.01495 | 79 | 75 |
Ras signaling pathway | 0.01495 | 145 | 76 |
Lysine degradation | 0.016507 | 33 | 66 |
Amphetamine addiction | 0.016687 | 45 | 72 |
Sphingolipid signaling pathway | 0.016687 | 79 | 76 |
Glutamatergic synapse | 0.016687 | 77 | 76 |
mRNA surveillance pathway | 0.01713 | 64 | 74 |
RNA transport | 0.01833 | 112 | 75 |
MAPK signaling pathway | 0.018745 | 166 | 77 |
Chronic myeloid leukemia | 0.01925 | 51 | 74 |
Estrogen signaling pathway | 0.022066 | 65 | 76 |
GABAergic synapse | 0.023522 | 59 | 73 |
p53 signaling pathway | 0.026352 | 48 | 73 |
Biosynthesis of unsaturated fatty acids | 0.027342 | 15 | 49 |
mTOR signaling pathway | 0.031797 | 45 | 70 |
Regulation of actin cytoskeleton | 0.037298 | 139 | 75 |
Protein processing in endoplasmic reticulum | 0.038084 | 112 | 74 |
cAMP signaling pathway | 0.038084 | 130 | 76 |
Oxytocin signaling pathway | 0.038084 | 104 | 77 |
Glycosaminoglycan biosynthesis - keratan sulfate | 0.039424 | 12 | 23 |
Central carbon metabolism in cancer | 0.04664 | 46 | 70 |
Melanogenesis | 0.04852 | 68 | 76 |